Journal List > Endocrinol Metab > v.26(1) > 1085917

Choi and Lee: A Case of Aldosterone-secreting Adrenocortical Carcinoma

Figures and Tables

Fig. 1
Abdomino-pelvic computed tomography of abdomen showed 6.4 × 4.2 × 5.7 cm sized lobulating contoured heterogeneous enhancing mass in left suprarenal area.
enm-26-36-g001
Fig. 2
Microscopic findings of the tumor show vascular tumor invasion (H&E staining, × 200) (A), and marked nuclear pleomorphism (H&E staining, × 400) (B).
enm-26-36-g002

References

1. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology. 2008. 11th ed. Philadelphia: Saunders Elsevier.
2. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989. 13:202–206.
3. Sasano H, Suzuki T, Moriya T. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol. 2006. 17:345–354.
4. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2009. 23:273–289.
5. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, BCordon-Cardo C, Jaques DP, Brennan MF. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol. 2002. 20:941–950.
6. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007. 356:2372–2380.
TOOLS
Similar articles